AstraZeneca secures FDA approval for Imfinzi combo in MIBC
The regulator granted the clearance under priority review based on findings from the multi-centre VOLGA Phase III clinical study.
The regulator granted the clearance under priority review based on findings from the multi-centre VOLGA Phase III clinical study.